Wave Life Sciences Shares Fall 19% After Public Offering News
By Stephen Nakrosis Shares of Wave Life Sciences were trading lower after hours following news the company commenced a $100 million underwritten public...
Stay updated with breaking news from Wave Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Stephen Nakrosis Shares of Wave Life Sciences were trading lower after hours following news the company commenced a $100 million underwritten public...
By Colin Kellaher Shares of Wave Life Sciences tumbled 25% in premarket trading Thursday after the clinical-stage RNA medicines company said it was raising...
Wave Life Sciences Ltd WVE has priced its previously announced underwritten public offering of 20 million shares at $5.00 per share with approximately $100…
CAMBRIDGE, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced
-- Health care stocks were mixed pre-bell Thursday as the Health Care Select Sector SPDR Fund was down a slight 0.1% and iShares Biotechnology ETF was recently 0.6% higher. WAVE Life Sciences was...